Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up - Journal of the Neurological Sciences
IJMS | Free Full-Text | New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration
Molecular and cellular changes in multiple sclerosis. The mechanisms of... | Download Scientific Diagram
Pharmaceuticals | Free Full-Text | Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility? | HTML
Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis | Semantic Scholar